🫁 The world's first inhaled antibody treatment for #NipahVirus is in development through a new EU-funded project, #HENIPROTECT.
Discover why it's a @who.int priority disease and how patients will help shape this research.

🫁 The world's first inhaled antibody treatment for #NipahVirus is in development through a new EU-funded project, #HENIPROTECT.
Discover why it's a @who.int priority disease and how patients will help shape this research.
🦇 HENIPROTECT aims to develop inhaled antibodies against Nipah virus.
ERINHA contributes its high-containment research expertise to this new six-year project.
Funded by the European Union.